TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
- Status
- COMPLETED
- Phase
- PHASE1
The French E3N Prospective Cohort Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
REO13 Melanoma With of Without GM-CSF
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
INCB039110 in Combination With Dabrafenib and Trametinib in Patients With BRAF-mutant Melanoma and Other Solid Tumors.
- Status
- TERMINATED
- Phase
- PHASE1
International Trial of the Efficacy and Safety of BCD-100 in Patients With Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy
- Status
- COMPLETED
- Phase
- N/A
Neoadjuvant Trial of Nivolumab in Combination With HF10 Oncolytic Viral Therapy in Resectable Stage IIIB, IIIC, IVM1a Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)
- Status
- COMPLETED
- Phase
- N/A
Pembrolizumab Effects on NK Cell Exhaustion in Melanoma (Merck NK-IIT)
- Status
- TERMINATED
- Phase
- PHASE2
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Vemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma Patients
- Status
- TERMINATED
- Phase
- PHASE2
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
The Effectiveness of Nivolumab Monotherapy as First-Line Therapy in Adults With Advanced Melanoma in Germany
- Status
- WITHDRAWN
- Phase
- N/A
Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States
- Status
- COMPLETED
- Phase
- N/A
Oral STAT3 Inhibitor, TTI-101, in Patients with Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Teaching Skin Self-Examination to First-degree Relatives of Melanoma Patients Using Mobile App Technology
- Status
- WITHDRAWN
- Phase
- NA
Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors
- Status
- COMPLETED
- Phase
- NA